How Many People Have Sleep Apnea? A Look at Global Prevalence
Sleep apnea is one of those conditions where the public numbers and the private reality rarely line up. It is enormously common, and most of the people who have it do not yet know they do. That gap, between how many people meet the clinical definition and how many actually carry a diagnosis on their chart, is what makes this question worth taking seriously.
Before I get into the numbers, a short disclosure. I am not a doctor or a sleep clinician. My background is in computer science. I write about sleep apnea because I have lived with it for more than a decade after eventually being diagnosed with severe obstructive sleep apnea and an AHI of 51, which sat undiagnosed for years before someone connected the dots. The undiagnosed statistic on this page is not an abstraction to me. It describes the version of myself who spent most of his working life exhausted without knowing why.
What follows is a research synthesis drawn from the best available global studies and from high authority health institutions. I have linked the primary sources so you can read them yourself.
The Global Picture
The most widely cited estimate of worldwide sleep apnea prevalence comes from a 2019 study published in The Lancet Respiratory Medicine. Adam Benjafield and colleagues used population data from sixteen countries and standard American Academy of Sleep Medicine scoring criteria to model prevalence across the rest of the world.
The headline figures from that study are striking.
About 936 million adults aged 30 to 69 worldwide are estimated to have at least mild obstructive sleep apnea, defined as an apnea-hypopnea index of five events per hour or higher.
Roughly 425 million adults in the same age range are estimated to have moderate to severe obstructive sleep apnea, defined as an apnea-hypopnea index of fifteen events per hour or higher.
These are the numbers behind the often repeated framing that almost a billion people worldwide have sleep apnea. Two important caveats are worth noting. The Benjafield model deliberately limited itself to adults aged 30 to 69, because that is the range where most population studies have collected reliable data. The true global figure that also includes younger adults, older adults, and children is almost certainly higher. The model also only covers obstructive sleep apnea, which is the most common form. Central sleep apnea, where the issue is with the brain’s breathing signals rather than the airway, sits outside these figures.
The Cleveland Clinic summarizes the same data in plainer terms: about one billion people between the ages of 30 and 69 around the world have obstructive sleep apnea. You can read their overview on the Cleveland Clinic sleep apnea page.
Sleep Apnea in the United States
The most often cited United States figure traces back to research led by Paul Peppard at the University of Wisconsin. Their work, published in the American Journal of Epidemiology, estimated that around 26 percent of adults aged 30 to 70 have at least mild sleep apnea, and that around 25 million United States adults meet the criteria.
Other estimates put the United States figure closer to 30 million when adjusted for population growth and rising obesity rates. The American Academy of Sleep Medicine has noted that the 25 million figure is conservative, because diagnostic criteria have tightened in ways that capture more cases than older population surveys did.
What these figures share, regardless of which number you prefer, is that the United States carries one of the highest absolute burdens of sleep apnea in the world, behind only China.
How Prevalence Varies by Region
The Benjafield modeling identified the four countries with the largest absolute populations of people with obstructive sleep apnea. China is first, followed by the United States, Brazil, and India. China alone is estimated to have over 170 million people with at least mild OSA, which reflects both the size of its adult population and the rising prevalence of risk factors like obesity and aging.
Estimates for European countries vary widely depending on the diagnostic criteria used and how recent the underlying study is. The HypnoLaus study, conducted in Switzerland, found a remarkably high prevalence when modern scoring criteria were applied. That study used sensitive home polysomnography and modern AASM 2012 scoring, which tends to flag more breathing events than older protocols, so the figures sit at the high end of the published range.
Across most population studies in developed countries, the broad pattern holds. Men have higher prevalence than women in middle age. Prevalence rises with age. Obesity is the single strongest modifiable risk factor.
Lower and middle income countries have less reliable prevalence data, which is itself a problem. People in those regions are not less affected. They are less measured.
The Undiagnosed Majority
The most arresting statistic on this entire topic is not a prevalence figure. It is the diagnostic gap.
The Sleep Foundation, drawing on the peer reviewed literature, estimates that 80 to 90 percent of people with obstructive sleep apnea are undiagnosed. In moderate to severe cases, where the risks to cardiovascular and metabolic health are most pronounced, undiagnosed rates may be even higher in certain populations. You can read their overview at the Sleep Foundation sleep statistics page.
A few reasons drive this gap.
The most common symptoms, loud snoring and daytime fatigue, are widely treated as personality quirks rather than clinical signs. A partner who snores is teased rather than referred. A person who is tired during the day is told to drink more coffee.
Sleep apnea also presents differently in women than in men, which has historically led to underdiagnosis. Women are more likely to report insomnia, morning headaches, mood changes, and persistent fatigue rather than the classic gasping arousals. I cover this gap in more detail on my page about sleep apnea in women.
Access to sleep studies remains uneven. Laboratory polysomnography is resource intensive. Home sleep apnea testing has expanded access significantly in the last decade, but availability still varies widely between countries and within healthcare systems.
Finally, denial is its own factor. Many people who suspect they may have sleep apnea avoid testing because they fear the verdict and the prospect of wearing a CPAP mask every night. I understand that fear. I felt it myself before my own diagnosis. In hindsight it was the worst possible reason to delay.
Who Is Most at Risk
Sleep apnea does not pick its victims at random. The Cleveland Clinic, Sleep Foundation, and the peer reviewed prevalence literature broadly agree on the major risk factors.
Sex and age matter. Men are diagnosed roughly two to three times more often than women, though this gap narrows after menopause. Prevalence rises significantly with age in both sexes.
Body weight is the single largest modifiable risk factor. Excess weight, particularly around the neck and upper airway, makes airway collapse during sleep more likely. The relationship is consistent across populations: more weight, more risk.
Anatomy plays a role independent of weight. A naturally narrow airway, a large tongue base, enlarged tonsils, a recessed lower jaw, or a deviated septum can all contribute. This is part of why sleep apnea can run in families.
Lifestyle factors compound the risk. Alcohol and sedatives relax the airway muscles. Smoking inflames the airway. Sleeping on the back tends to worsen events compared to side sleeping for many people.
Medical conditions raise the odds further. Hypertension, type 2 diabetes, atrial fibrillation, polycystic ovary syndrome, and hypothyroidism are all associated with higher rates of OSA.
Why Prevalence Appears to Be Rising
The published prevalence of sleep apnea has climbed steadily over the past two decades. Some of that increase is real. Rates of obesity, the strongest modifiable risk factor, have risen across most of the world. Populations are aging. Both trends push the underlying prevalence higher.
Part of the increase, however, reflects how we measure. The AASM scoring criteria became more sensitive in 2012, which means studies after that date flag breathing events that earlier studies would have missed. Home sleep testing has become cheaper and more accessible, which has uncovered cases that previously would have gone unmeasured. Better awareness among general practitioners has led to more referrals from primary care.
In other words, sleep apnea is both more common and better detected than it was a generation ago. Most experts believe the underlying biological prevalence is genuinely climbing, but the rate of climb is amplified by improved measurement.
What Untreated Sleep Apnea Costs
The reason prevalence figures matter is that untreated sleep apnea is not benign. The list of associated health consequences is long, but a few stand out.
Cardiovascular disease and stroke risk are meaningfully elevated in people with untreated moderate to severe sleep apnea. The repeated drops in blood oxygen during the night place stress on the heart and blood vessels.
Type 2 diabetes and insulin resistance show a strong bidirectional relationship with sleep apnea. Each makes the other worse over time.
Mental health suffers. Chronic sleep deprivation affects mood, memory, and cognitive performance. Depression and anxiety are more common in people with untreated sleep apnea than in the general population.
Daytime drowsiness raises the risk of motor vehicle crashes. This is not a minor risk. Multiple studies have found that untreated sleep apnea raises crash risk in commercial drivers in particular, which is why many transportation regulators now screen for it.
What to Do If You Suspect You Have Sleep Apnea
If anything on this page resembles your situation, the practical next step is straightforward. Talk to a doctor. They will typically refer you for a sleep study, either at a sleep lab or at home. The home option has improved considerably over the last decade and is suitable for most adults with suspected moderate to severe OSA.
If you want to think through the symptoms first, I wrote a more focused piece on recognizing the signs of sleep apnea. For readers who want to dig further into the numbers, I keep a broader collection of sleep apnea statistics covering everything from treatment outcomes to economic costs. The most clinically important number is the one a sleep study will give you back: your AHI, or apnea-hypopnea index, which is how severity is graded.
Treatment for diagnosed obstructive sleep apnea most often starts with CPAP therapy, which keeps the airway open with a continuous flow of pressurized air. It is not the only option, but it is the most studied and the most effective for moderate to severe cases.
Closing Thought
The headline number, almost a billion adults worldwide with obstructive sleep apnea, is large enough to be hard to feel. The number underneath it, the eight or nine out of every ten of those people who do not yet know they have it, is the one that has stayed with me. For more than a decade before my own diagnosis I was one of them. Most of the people in your life who snore loudly and feel exhausted during the day are probably still one of them now.
The path from undiagnosed to diagnosed is not glamorous. It involves a conversation with a doctor, a night with a sleep monitor, and for many people a period of getting used to a CPAP machine. The path from there to feeling like a different person is shorter than most people expect.
Sources
Benjafield AV, Ayas NT, Eastwood PR, et al. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. The Lancet Respiratory Medicine, 2019. https://doi.org/10.1016/S2213-2600(19)30198-5
Cleveland Clinic. Sleep Apnea: What It Is, Causes, Symptoms and Treatment. https://my.clevelandclinic.org/health/diseases/8718-sleep-apnea
Sleep Foundation. Sleep Statistics. https://www.sleepfoundation.org/how-sleep-works/sleep-facts-statistics
⚠️ MEDICAL DISCLAIMER This blog provides general information only and is not a substitute for professional medical advice, diagnosis, or treatment. Sleep apnea is a serious condition, and CPAP equipment should be used under proper medical supervision. Always consult your doctor or sleep specialist before starting, stopping, or changing any therapy. I share personal experiences as a CPAP user, not as a medical professional. Individual results vary. For medical guidance, please consult a qualified clinician or the American Academy of Sleep Medicine (aasm.org).
